Add like
Add dislike
Add to saved papers

Cyaarside (CAs-) and 1,3-Diarsaallendiide (AsCAs2-) Ligands Coordinated to Uranium and Generated via Activation of the Arsaethynolate Ligand (OCAs-).

Angewandte Chemie 2018 November 15
Reaction of the trivalent uranium complex [((Ad,MeArO)3N)-U(DME)] with one molar equivalent [Na(OCAs)(dioxane)3], in the presence of 2.2.2-crypt, yields [Na(2.2.2-crypt)]-[{((Ad,MeArO)3N)-UIV(THF)}-(μ-O)-{((Ad,MeArO)3N)-UIV(CAs)}] (1), which is the arsenic containing analogue of the previously reported, μ-oxo-bridged di-uranium cyaphide complex. The structural characterization of complex 1 reveals the first example of a coordinated η1-cyaarside ligand (CAs-). The terminal CAs- anionic ligand formation is promoted by the highly reducing, oxo-philic uranium(III) precursor [((Ad,MeArO)3N)-U(DME)] and proceeds through reductive C-O bond cleavage of the bound arsaethynolate anion, OCAs-. If two equivalents of OCAs- are allowed to react with the uranium(III) precursor, the binuclear, µ-oxo-bridged diuran-ium(IV/IV) complex [Na(2.2.2-crypt)]2-[{((Ad,MeArO)3N)-UIV}2-(μ-O)(μ-AsCAs)] (2), comprising the hitherto unknown μ:η1,η1-coordinated (AsCAs)2- ligand, is isolated. The mechanistic pathway en route to the metalla-arsa-allene complex forma-tion likely is the decarbonylation of a dimeric inter-mediate formed in the reaction of 1 with OCAs-. An alternative path-way to complex 2 is the conver-sion of complex 1 to 2 by addition of one further equivalent of OCAs-. The mechanistic proposals are corroborated by DFT calculations.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app